Rats displaying distinct exploratory activity also have different expression patterns of γ-aminobutyric acid- and cholecystokinin-related genes in brain regions

Brain Research

Volumn 1100, Issue 1, 2006, Pages 21-31

  Nelovkov, Aleksei ^a   Areda, Tarmo ^a   Innos, Jürgen ^a   Kõks, Sulev ^a   Vasar, Eero ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Amygdala; CCK; Elevated plus maze; Exploratory activity; Frontal cortex; GABA; Gene expression; LsAMP; Periaqueductal gray; Selection of rat

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; LIMBIC SYSTEM ASSOCIATED MEMBRANE PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOWN REGULATION; EXPLORATORY BEHAVIOR; EXPOSURE; FRONTAL CORTEX; GENE EXPRESSION; LIMBIC SYSTEM; MALE; MAZE TEST; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RAT STRAIN; UPREGULATION;

AMYGDALA; ANIMALS; ANXIETY; BRAIN CHEMISTRY; CHOLECYSTOKININ; EMOTIONS; EXPLORATORY BEHAVIOR; GAMMA-AMINOBUTYRIC ACID; MALE; PERIAQUEDUCTAL GRAY; PREFRONTAL CORTEX; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33745918942     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.05.007     Document Type: Article

References (49)

1. Bert B., Fink H., Sohr R., and Rex A. Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety. Pharmacol. Biochem. Behav. 70 (2001) 411-420
2. Bradwejn J., and de Montigny C. Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones. Nature 312 (1984) 363-364
3. Bueno C.H., Zangrossi Jr. H., Nogueira R.L., Soares V.P., and Viana M.B. Panicolytic-like effect induced by the stimulation of GABA(A) and GABA(B) receptors in the dorsal periaqueductal grey of rats. Eur. J. Pharmacol. 516 (2005) 239-246
4. Chacur C., Raymond R., Hipolide D.C., Giugliano E.B., Leite J.R., and Nobrega J.N. Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect. Neurosci. Lett. 269 (1999) 29-32
5. Chen Q., Nakajima A., Meacham C., and Tang Y.-P. Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse. Proc. Natl. Acad. Sci. 103 (2006) 3881-3886
6. Clark C.R., Daum P., and Hughes J. A study of the cerebral cortex cholecystokinin receptor using two radiolabelled probes: evidence for a common CCK 8 and CCK 4 cholecystokinin receptor binding site. J. Neurochem. 46 (1986) 1094-1101
7. Cope D.W., Maccaferri G., Marton L.F., Roberts J.D., Cobden P.M., and Somogyi P. Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurons target different domains of pyramidal cells in the CA1 area of the rat hippocampus. Neuroscience 109 (2002) 63-80
8. Da Cunha C., Wolfman C., Levi de Stein M., Ruschel A.C., Izquierdo I., and Medina J.H. Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist. Funct. Neurology 7 (1992) 401-405
9. Espejo E.F. Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav. Brain Res. 86 (1997) 105-112
10. Fekete M., Lengyel A., Hegedus B., Penke B., Zarandy M., Toth G., and Telegdy G. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats. Eur. J. Pharmacol. 98 (1984) 79-91
11. Ferraro L., Beani L., Trist D., Reggiani A., and Bianchi C. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices. J. Neurochem. 73 (1999) 1973-1981
12. Hama Y., and Ebadi M. Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics. Neurochem. Res. 12 (1987) 729-737
13. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedeberg's Arch. Pharmacol. 327 (1984) 1-5
14. Harro J., Kiivet R.A., Lang A., and Vasar E. Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav. Brain Res. 39 (1990) 63-71
15. Hendry S.H., Jones E.G., DeFelipe J., Schmechel D., Brandon C., and Emson P.C. Neuropeptide-containing neurons of the cerebral cortex are also GABAergic. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 6526-6530
16. Kõks S., Vasar E., Soosaar A., Lang A., Volke V., Võikar V., Bourin M., and Männistö P.T. Relation of exploratory behaviour of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels. Eur. Neuropsychopharmacol. 7 4 (1997) 289-294
17. Kõks S., Luuk H., Nelovkov A., Areda T., and Vasar E. A screen for genes induced in the amygdaloid area during cat odor exposure. Genes Brain Behav. 3 (2004) 80-89
18. Kosaka T., Kosaka K., Tateishi K., Hamaoka Y., Yanaihara N., Wu J.Y., and Hama K. GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus. J. Comp. Neurol. 239 (1985) 420-430
19. Kozorovitskiy Y., and Gould E. Dominance hierarchy influences adult neurogenesis in the dentate gyrus. J. Neurosci. 24 (2004) 6755-6759
20. Landgraf R., and Wigger A. High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav. Genet. 32 (2002) 301-314
21. Liebsch G., Linthorst A.C., Neumann I.D., Reul J.M., Holsboer F., and Landgraf R. Behavioural, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behaviour. Neuropsychopharmacology 19 (1998) 381-396
22. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92 (1987) 180-185
23. McDonald A.J., and Pearson J.C. Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala. Neurosci. Lett. 100 (1989) 53-58
24. McDonald A.J., Mascagni F., and Muller J.F. Immunocytochemical localization of GABABR1 receptor subunits in the basolateral amygdala. Brain Res. 1018 (2004) 147-158
25. Miller K.K., Hoffer A., Svoboda K.R., and Lupica C.R. Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons. J. Neurosci. 17 (1997) 4994-5003
26. Mombereau C., Kaupmann K., Gassmann M., Bettler B., van der Putten H., and Cryan J.F. Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits. NeuroReport 16 (2005) 307-310
27. Nelovkov A., Philips M.A., Kõks S., and Vasar E. Rats with low exploratory activity in the elevated plus-maze have the increased expression of limbic system-associated membrane protein gene in the periaqueductal grey. Neurosci. Lett. 352 (2003) 179-182
28. Netto C.F., and Guimaraes F.S. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray. Neuropsychopharmacology 29 (2004) 101-107
29. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., and Roques B.P. International Union of Pharmacology: XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 51 (1999) 745-781 (Review)
30. Panksepp J. Affective Neuroscience: the Foundations of Human and Animal Emotions (1998), Oxford Univ. Press, New York
31. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24 (1986) 525-529
32. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1985) 149-167
33. Perez de la Mora M., Hernandez-Gomez A.M., Mendez-Franco J., and Fuxe K. Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas. Eur. J. Pharmacol. 250 (1993) 423-430
34. Pimenta A.F., Zhukareva V., Barbe M.F., Reinoso B.S., Grimley C., Henzel W., Fischer I., and Levitt P. The limbic system-associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting. Neuron 15 (1995) 287-297
35. Pratt J.A., and Brett R.R. The benzodiazepine receptor inverse agonist FG 7142 induces cholecystokinin gene expression in rat brain. Neurosci. Lett. 184 (1995) 197-200
36. Raab A., Dantzer R., Michaud B., Mormede P., Taghzouti K., Simon H., and Le Moal M. Behavioural, physiological and immunological consequences of social status and aggression in chronically coexisting resident-intruder dyads of male rats. Physiol. Behav. 36 (1986) 223-228
37. Rägo L., Kiivet R.A., Harro J., and Põld M. Behavioural differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 337 (1988) 675-678
38. Rägo L., Adojaan A., Harro J., and Kiivet R.A. Correlation between exploratory activity in an elevated plus-maze and number of central and peripheral benzodiazepine binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 343 (1991) 301-306
39. Rasmussen K., Helton D.R., Berger J.E., and Scearce E. The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle. NeuroReport 5 (1993) 154-156
40. Raud S., Rünkorg K., Veraksitš A., Reimets A., Nelovkov A., Abramov U., Matsui T., Bourin M., Volke V., Kõks S., and Vasar E. Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice. Psychopharmacology (Berlin) 168 (2003) 417-425
41. Raud S., Innos J., Abramov U., Reimets A., Kõks S., Soosaar A., Matsui T., and Vasar E. Targeted invalidation of CCK(2) receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test. Psychopharmacology (Berlin). 181 (2005) 347-357
42. Rodgers R.J. Animal models of 'anxiety': where next?. Behav. Pharmacol. 8 (1997) 477-496
43. Russo A.S., Guimaraes F.S., De Aguiar J.C., and Graeff F.G. Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety. Psychopharmacology (Berlin) 110 (1993) 198-202
44. Singh L., Field M.J., Vass C.A., Hughes J., and Woodruff G.N. The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988. Br. J. Pharmacol. 105 (1992) 8-10
45. Swanson L.W. Brain Maps: Structure of the Rat Brain. 2nd ed. (1998), Elsevier Science B.V., Amsterdam
46. Van Dijk A., Richards J.G., Trzeciak A., Gillessen D., and Mohler H. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand. J. Neurosci. 4 (1984) 1021-1033
47. Wang H., Zhu Y.Z., Wong P.T., Farook J.M., Teo A.L., Lee L.K., and Moochhala S. cDNA microarray analysis of gene expression in anxious PVG and SD rats after cat-freezing test. Exp. Brain Res. 149 4 (2003) 413-421
48. Wunderlich G.R., Raymond R., DeSousa N.J., Nobrega J.N., and Vaccarino F.J. Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behaviour. Psychopharmacology (Berlin) 164 (2002) 193-199
49. Zanoveli J.M., Netto C.F., Guimaraes F.S., and Zangrossi Jr. H. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze. Peptides 25 (2004) 1935-1941